Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 701-008-3 | CAS number: -
Toxicological Summary
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 9.32 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- Overall assessment factor (AF):
- 3
- Modified dose descriptor starting point:
- NOAEC
Acute/short term exposure
- Hazard assessment conclusion:
- no-threshold effect and/or no dose-response information available
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no-threshold effect and/or no dose-response information available
Acute/short term exposure
- Hazard assessment conclusion:
- no-threshold effect and/or no dose-response information available
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 19.83 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- Overall assessment factor (AF):
- 12
- Modified dose descriptor starting point:
- NOAEL
Acute/short term exposure
- Hazard assessment conclusion:
- no-threshold effect and/or no dose-response information available
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no-threshold effect and/or no dose-response information available
Acute/short term exposure
- Hazard assessment conclusion:
- no-threshold effect and/or no dose-response information available
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - workers
General
The DNELs presented in this section have been developed following REACH technical guidance on route-to route extrapolation (ECHA, 2008), and ECETOC guidance on assessment factors (ECETOC, 2003).
Scientific justification for this approach reflects REACH guidance which notes that the overall assessment factor applied to an experimental NOAEL when developing a DNEL is multiplicative in nature, and that care should be taken to avoid double counting several aspects when multiplying the individual factors (ECHA, 2008). As a consequence, no additional factor has been included in these DNELs to address “residual” interspecies variation present following allometric scaling since this is largely accounted for in the default assessment factor proposed by ECETOC for intraspecies variability; and an assessment factor of 3 was considered appropriate to account for variability present in worker groups, while a value of 5 is considered appropriate for the general population, since these approximate the 90th percentile and 95th percentile, respectively, of human data analysed by ECETOC.
ECETOC (2003) Derivation of Assessment Factors for Human Health Risk Assessment. Technical Report No. 86, ECETOC Brussels, February 2003.
ECHA (2008) Guidance of information requirements and chemical safety assessment. Chapter R.8: Characterisation of dose [concentration]-response for human health.
Acute toxicity
A DNEL for acute toxicity should be derived if an acute hazard leading to acute toxicity (e.g. classified under DSD) has been identified and there is a potential for high peak exposures. If no hazard has been identified then a DNEL for acute toxicity is unnecessary as the long-term DNEL will be sufficient to ensure that adverse effects do no occur. S278 is neither acutely toxic nor is it an irritant (eye, skin or respiratory tract) and therefore no acute DNELs (systemic or local) have been calculated.
Long-term systemic toxicity - Workers
While no repeated dose oral toxicity data are available on S278, oral studies on three other phthalates, Santicizer 261 (3-week study), DINP (2-year study) and BBP (90-day study), returned NOAELs of 60, 17 and 151 mg/kg bw/day, respectively. The NOAEL for DINP will be used as a surrogate for the derivation of a long-term systemic DNEL for S278 since (i) the information originates from a modern chronic exposure study, and (ii) the magnitude of the NOAEL is relatively low. In recognition of the likely conservative nature of the resulting DNEL, no additional assessment factor will be applied to account for uncertainties associated with read-across from DINP to S278.
Inhalation DNEL (systemic)
Dose descriptor
A rat chronic (2-year) NOAEL of 17 mg/kg bw/d will be used as the starting point.
Modification of dose descriptor
The equivalent rat inhalation NOAEC will be derived using route-to-route extrapolation. Uptake of 75% after inhalation and 50% after ingestion has been assumed (see discussion of toxicokinetics).
The inhalatory NOAEC is calculated as follows (ECHA (2008); Figure R.8-3):
NOAECinhalation = NOAELoral x 1/sRVrat 8hr x ABSoral-rat/ABSinh-human x sRVhuman/wRVhuman
= 17 x 1/0.38 x 50/75 x 6.7/10 = 19.98 mg/m3
The NOAEC is then adjusted for differences in exposure pattern (5 d/wk for workers, 7 d/wk for the underlying rat chronic study):
NOAECinhalation = 7/5 x 19.98 = 27.97 mg/m3
Assessment factors
Uncertainty | AF (ECETOC) | Justification |
Interspecies differences | 1 - | default for inhalation route residual |
Intraspecies differences | 3 | default AF for workers |
Differences in duration of exposure | 1 | default for chronic exposure |
Dose response and endpoint specific/severity issues | 1 | default AF |
Quality of database | 1 | default AF |
Overall AF | 3 |
|
DNELl-t inhal-systemic = 27.97 / 3 = 9.32 mg/m3
Dermal DNEL (systemic)
Dose descriptor
A rat chronic (2-year) NOAEL of 17 mg/kg bw/d will be used as the starting point.
Modification of dose descriptor
The equivalent rat dermal NOAEL will be derived using route-to-route extrapolation. Uptake of 5% by the skin and 50% after ingestion has been assumed (see discussion of toxicokinetics)
The dermal NOAEL may be calculated as follows:
NOAELdermal = NOAELoral x ABSoral-rat/ABSdermal-human
= 17 x 50/5 = 170 mg/kg bwt/d
The NOAEL is then adjusted for differences in exposure pattern (5 d/wk for workers, 7 d/wk for the underlying rat chronic study):
NOAELdermal = 7/5 x 170 = 238 mg/kg bwt/d
Assessment factors
Uncertainty | AF (ECETOC) | Justification |
Interspecies differences | 4 - | default for rat residual |
Intraspecies differences | 3 | default AF for workers |
Differences in duration of exposure | 1 | default for chronic exposure |
Dose response and endpoint specific/severity issues | 1 | default AF |
Quality of database | 1 | default AF |
Overall AF | 12 |
|
DNELl-t dermal-systemic = 238 / 12 = 19.83 mg/kg bw/d
Long-term local effects
No long-term local effects have been reported for S278 or related phthalate esters, hence no long-term local DNELs have been calculated.
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 1.97 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- Overall assessment factor (AF):
- 5
- Modified dose descriptor starting point:
- NOAEC
Acute/short term exposure
- Hazard assessment conclusion:
- no-threshold effect and/or no dose-response information available
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no-threshold effect and/or no dose-response information available
Acute/short term exposure
- Hazard assessment conclusion:
- no-threshold effect and/or no dose-response information available
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 8.5 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- Overall assessment factor (AF):
- 20
- Modified dose descriptor starting point:
- NOAEL
Acute/short term exposure
- Hazard assessment conclusion:
- no-threshold effect and/or no dose-response information available
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no-threshold effect and/or no dose-response information available
Acute/short term exposure
- Hazard assessment conclusion:
- no-threshold effect and/or no dose-response information available
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.85 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- Overall assessment factor (AF):
- 20
- Modified dose descriptor starting point:
- NOAEL
Acute/short term exposure
- Hazard assessment conclusion:
- no-threshold effect and/or no dose-response information available
DNEL related information
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - General Population
General
The DNELs presented in this section have been developed following REACH technical guidance on route-to route extrapolation (ECHA, 2008), and ECETOC guidance on assessment factors (ECETOC, 2003).
Scientific justification for this approach reflects REACH guidance which notes that the overall assessment factor applied to an experimental NOAEL when developing a DNEL is multiplicative in nature, and that care should be taken to avoid double counting several aspects when multiplying the individual factors (ECHA, 2008). As a consequence, no additional factor has been included in these DNELs to address “residual” interspecies variation present following allometric scaling since this is largely accounted for in the default assessment factor proposed by ECETOC for intraspecies variability; and an assessment factor of 3 was considered appropriate to account for variability present in worker groups, while a value of 5 is considered appropriate for the general population, since these approximate the 90th percentile and 95th percentile, respectively, of human data analysed by ECETOC.
ECETOC (2003) Derivation of Assessment Factors for Human Health Risk Assessment. Technical Report No. 86, ECETOC Brussels, February 2003.
ECHA (2008) Guidance of information requirements and chemical safety assessment. Chapter R.8: Characterisation of dose [concentration]-response for human health.
Acute toxicity
A DNEL for acute toxicity should be derived if an acute hazard leading to acute toxicity (e.g. classified under DSD) has been identified and there is a potential for high peak exposures. If no hazard has been identified then a DNEL for acute toxicity is unnecessary as the long-term DNEL will be sufficient to ensure that adverse effects do no occur. S278 is neither acutely toxic nor is it an irritant (eye, skin or respiratory tract) and therefore no acute DNELs (systemic or local) have been calculated.
Long-term systemic toxicity – General population
While no repeated dose oral toxicity data are available on S278, oral studies on three other phthalates, Santicizer 261 (3-week study), DINP (2-year study) and BBP (90-day study), returned NOAELs of 60, 17 and 151 mg/kg bw/day, respectively. The NOAEL for DINP will be used as a surrogate for the derivation of a long-term systemic DNEL for S278 since (i) the information originates from a modern chronic exposure study, and (ii) the magnitude of the NOAEL is relatively low. In recognition of the likely conservative nature of the resulting DNEL, no additional assessment factor will be applied to account for uncertainties associated with read-across from DINP to S278.
Inhalation DNEL (systemic)
Dose descriptor
A rat chronic (2-year) NOAEL of 17 mg/kg bw/d will be used as the starting point.
Modification of dose descriptor
The equivalent rat inhalation NOAEC will be derived using route-to-route extrapolation. Uptake of 75% after inhalation and 50% after ingestion has been assumed (see discussion of toxicokinetics).
The inhalatory NOAEC is calculated as follows (ECHA (2008); Figure R.8-3):
NOAECinhalation = NOAELoral x 1/sRVrat 24hr x ABSoral-rat/ABSinh-human x ABSinh-rat/ABSinh-human
= 17 x 1/1.15 x 50/75 = 9.86 mg/m3
No additional correction is required for differences in exposure pattern (7 d/wk for general population, 7 d/wk for the underlying rat chronic study).
Assessment factors
Uncertainty | AF (ECETOC) | Justification |
Interspecies differences | 1 - | default for inhalation route residual |
Intraspecies differences | 5 | default AF for general population |
Differences in duration of exposure | 1 | default for chronic exposure |
Dose response and endpoint specific/severity issues | 1 | default AF |
Quality of database | 1 | default AF |
Overall AF | 5 |
|
DNELl-t inhal-systemic = 9.86 / 5 = 1.97 mg/m3
Dermal DNEL (systemic)
Dose descriptor
A rat chronic (2-year) NOAEL of 17 mg/kg bw/d will be used as the starting point.
Modification of dose descriptor
The equivalent rat dermal NOAEL will be derived using route-to-route extrapolation. Uptake of 5% by the skin and 50% after ingestion has been assumed (see discussion of toxicokinetics)
The dermal NOAEL may be calculated as follows:
NOAELdermal = NOAELoral x ABSoral-rat/ABSdermal-human
= 17 x 50/5 = 170 mg/kg bwt/d
No additional correction is required for differences in exposure pattern (7 d/wk for general population, 7 d/wk for the underlying rat chronic study).
Assessment factors
Uncertainty | AF (ECETOC) | Justification |
Interspecies differences | 4 - | default for rat residual |
Intraspecies differences | 5 | default AF for workers |
Differences in duration of exposure | 1 | default for chronic exposure |
Dose response and endpoint specific/severity issues | 1 | default AF |
Quality of database | 1 | default AF |
Overall AF | 20 |
|
DNELl-t dermal-systemic = 170 / 20 = 8.5 mg/kg bw/d
Oral DNEL (systemic)
Dose descriptor
A rat chronic (2-year) NOAEL of 17 mg/kg bw/d will be used as the starting point.
Modification of dose descriptor
The extent of uptake from the gastrointestinal tract will be assumed to be identical for rats and humans. No additional correction is required (7 d/wk for general population, 7 d/wk for the underlying rat chronic study)
Assessment factors
Uncertainty | AF (ECETOC) | Justification |
Interspecies differences | 4 - | default for rat residual |
Intraspecies differences | 5 | default AF for workers |
Differences in duration of exposure | 1 | default for chronic exposure |
Dose response and endpoint specific/severity issues | 1 | default AF |
Quality of database | 1 | default AF |
Overall AF | 20 |
|
DNELl-t dermal-systemic = 17 / 20 = 0.85 mg/kg bw/d
Long-term local effects
No long-term local effects have been reported for S278 or related phthalate esters, hence no long-term local DNELs have been calculated.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Route: .live1